Friday, August 18, 2017
Company Reports Revenue of $5.3 Million for Q2 2017-  Continued Progress on Building a Consumer Products Platform Around TruNiagen®- IRVINE, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (CDXC), an innovator of proprietary health, wellness and nutritional ingredients,...
Today AQMS traded off 23%, hitting a new year low. This comes about a week after pre-announcing revenues for the second quarter. Which, obviously, means that something else has gone wrong, right? Well, that answer is not so obvious. Here...
Tailwinds' Take: another customer with name brand recognition demonstrating the competitive positioning of VUZI. AR continues to be the hottest space in tech, and Vuzix is the only pure play and the industry leader.  ROCHESTER, N.Y., Aug. 10, 2017 /PRNewswire/...
Tailwinds' Take: Resonant is moving firmly into revenue generation as they now have a handset in the market containing their filter design. This is a big milestone for the Company which the market has ignored so far.  GOLETA, CA --...
Tailwinds' Take: having been at the facility yesterday, I'm impressed with what the Company has accomplished. The second quarter is not important, it's about when they'll get to scale. If the Company maintains guidance, the stock could be demonstrably...
Tailwinds' Take: another quarter of growth with great guidance. Post the offering, Vuzix is fully funded. The Company is a leader in a hot space. With new customers coming, business booming and all the cash needed for success, Vuzix...
Tailwinds' Take: HCSC and Anthem are the two largest Blues. Per company guidance, one could reasonably expect both of them to be clients by year end. They represent 50% of all the Blue business, so this story is just...
Tailwinds' Take:  a big step for Patriot One, they are on track for imminent approval. "Booking sales into 2018", without an approved product, just shows the pent up demand for their offering.  TORONTO, ON (MARKETWIRED – August 9, 2017) – Patriot...
Tailwinds' Take: We didn't expect a strong quarter and it was even worse than we thought. However, we are invested in POLA for the future, and that is looking very bright. "We believe the second quarter financial performance was...
Tailwinds' Take: CYRX is in a sweet spot and will be for at least the next couple of years as they will continue to gain market share and revenue growth is set to go hyperbolic. The stock will likely...
Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address